Clinical Trials Browser

NIH × Melanoma × Lapatinib × Clear all

NCT01264081 2019-11-13

Lapatinib in Stage IV Melanoma With ERBB4 Mutations

Phase 2 Terminated

34 enrolled 11 charts

Melanoma, Skin Neoplasms